Recent Finacing
Recent Raise
Capnia develops a nasal carbon dioxide delivery therapy for treating migraines and rhinitis, with its device and formulation currently in clinical development in Palo Alto, California.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
